StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Trading Down 4.2 %
NYSE CO opened at $1.15 on Monday. The stock’s fifty day moving average price is $1.23 and its 200-day moving average price is $1.35. The stock has a market cap of $139.78 million, a P/E ratio of 1.80 and a beta of 0.16. Global Cord Blood has a 12 month low of $2.03 and a 12 month high of $5.50.
About Global Cord Blood
Further Reading
- Five stocks we like better than Global Cord Blood
- What is the S&P/TSX Index?
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Investing in Commodities: What Are They? How to Invest in Them
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- The How and Why of Investing in Gold Stocks
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.